Reactive Hydrogen-Driven Dehydroxylation of Hydroxyapatite Enables Anti-Ostwald Ripening of Ag Nanoparticles for Ethanol Valorization to Aromatics
Journal of the American Chemical Society · 22.04.2026 · 148 (15) · 16459-16468
DOI: 10.1021/jacs.6c03225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 10.04.2026. Verfasst von Danhui Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, Liaoning Key Laboratory for Catalytic Conversion of Carbon Resources, School of Chemical Engineering, Dalian …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Binhai Laboratory.
Abstract (Originalsprache)
The selective conversion of biomass-derived ethanol to high-value chemicals remains challenging due to the complex reaction pathways involving dehydrogenation, C-C coupling, dehydration, and particularly for aromatic products, aromatization of reactive intermediates. Herein, we designed a silver-containing hydroxyapatite catalyst (Ag/HAP) enabling ethanol upgrading to methylbenzyl alcohols and methylbenzaldehydes with a record-high aromatics selectivity of 77.8% and a yield of 33.3%. Notably, the average Ag particle size underwent a reduction from 1.27 nm in the fresh catalyst to 0.85 nm after five catalytic cycles, which represented a clear departure from the typical sintering tendency of Ag nanoparticles during reaction. In situ diffuse reflectance infrared Fourier transform spectroscopy combined with isotopic labeling mass spectrometry revealed that reactive hydrogen species (H*), generated either from ethanol dehydrogenation or external hydrogen donors, induced dehydroxylation of HAP to form the oxygen vacancies. Density functional theory calculations confirmed that the abundant oxygen vacancies in Ag/HAP favored the dispersion of Ag nanoparticles, manifesting as anti-Ostwald ripening under reaction conditions and resulting in a size reduction of Ag nanoparticles. X-ray photoelectron spectroscopy indicated the coexistence of metallic (Ag0) and cationic (Ag+) silver species, wherein Ag0 promoted ethanol dehydrogenation to acetaldehyde, while Ag+ facilitated aldehyde coupling and subsequent aromatization. Their cooperative interplay with an oxygen-vacancy-rich HAP accounted for the high selectivity toward aromatic products. This study provides valuable insights and a transferable approach for the rational design of active and durable catalysts resistant to Ostwald ripening.
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals, Liaoning Key Laboratory for Catalytic Conversion of Carbon Resources, School of Chemical Engineering, Dalian University of Technology, Dalian 116024 Liaoning, China.
- Liaoning Binhai Laboratory, Dalian 116023 Liaoning, China.
ORCID-Profile: Wen-Cui Li, Tao Wu, An-Hui Lu
Förderung
- National Natural Science Foundation of China
- Liaoning Binhai Laboratory
Zitieren
APA
Sun, D., Li, W. C., Wu, T., Qiao, Y. F., Wang, Z., & Lu, A. H. (2026). Reactive Hydrogen-Driven Dehydroxylation of Hydroxyapatite Enables Anti-Ostwald Ripening of Ag Nanoparticles for Ethanol Valorization to Aromatics. Journal of the American Chemical Society, 148(15), 16459-16468. https://doi.org/10.1021/jacs.6c03225
Vancouver
Sun D, Li WC, Wu T, Qiao YF, Wang Z, Lu AH. Reactive Hydrogen-Driven Dehydroxylation of Hydroxyapatite Enables Anti-Ostwald Ripening of Ag Nanoparticles for Ethanol Valorization to Aromatics. Journal of the American Chemical Society. 2026;148(15):16459-16468. doi:10.1021/jacs.6c03225
BibTeX
@article{Sun2026,
author = {Sun, Danhui and Li, Wen-Cui and Wu, Tao and Qiao, Yi-Fan and Wang, Zihao and Lu, An-Hui},
title = {Reactive Hydrogen-Driven Dehydroxylation of Hydroxyapatite Enables Anti-Ostwald Ripening of Ag Nanoparticles for Ethanol Valorization to Aromatics},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {15},
pages = {16459--16468},
doi = {10.1021/jacs.6c03225}
}
EUVIMED